News from NORD

More Than 100 Patient Organizations Join NORD in Supporting the RARE Act


 

NORD has sent a letter to Congress, signed by more than 100 patient advocacy organizations, in support of the Rare disease Advancement, Research, and Education Act of 2018 (H.R.5115) or the “RARE Act of 2018.” Read NORD’s letter to see how this proposed legislation would help patients and families affected by rare diseases, medical researchers, and clinicians seeking to provide optimal care for their patients.

Recommended Reading

Intraventricular enzyme replacement slows CLN2 disease progression
MDedge Neurology
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Neurology
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Neurology
RFPs Available for the Study of Three Rare Diseases
MDedge Neurology
More Than 100 Patient Organizations Join NORD in Supporting the RARE Act
MDedge Neurology
Medical Nutrition Equity Act Capitol Hill Day Planned for June 1
MDedge Neurology
NORD and Other Patient Organizations Oppose Short-Term, Limited-Duration Health Plans
MDedge Neurology
Running for Rare Team Participates in Boston Marathon to Raise Funds for Undiagnosed Patients
MDedge Neurology
NCATS Unveils Toolkit for Patient-Focused Therapy Development
MDedge Neurology
NORD Updates Educational Rare Disease Reports
MDedge Neurology